News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
525,670 Results
Type
Article (13035)
Company Profile (142)
Press Release (512708)
Multimedia
Podcasts (25)
Webinars (8)
Section
Business (181787)
Career Advice (659)
Deals (28304)
Drug Delivery (28)
Drug Development (56556)
Employer Resources (41)
FDA (10438)
Job Trends (9344)
News (258064)
Policy (19993)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (719)
Accelerated approval (32)
ADA (22)
Adcomms (4)
Allergies (105)
Alliances (35237)
ALS (123)
Alzheimer's disease (1089)
Antibody-drug conjugate (ADC) (305)
Approvals (11017)
Artificial intelligence (382)
ASCO (175)
Autoimmune disease (241)
Automation (37)
Bankruptcy (293)
Best Places to Work (7498)
BIO (39)
Biologics (2)
BIOSECURE Act (3)
Biosimilars (142)
BioSpace Insights (32)
Biotechnology (92)
Bladder cancer (143)
Brain cancer (34)
Breast cancer (536)
Cancer (3987)
Cardiovascular disease (247)
Career advice (570)
Career pathing (10)
CAR-T (209)
CDC (11)
Celiac Disease (1)
Cell therapy (570)
Cervical cancer (37)
Clinical research (50910)
Collaboration (1396)
Commercialization (5)
Company closure (3)
Compensation (1485)
Complete response letters (41)
COVID-19 (999)
CRISPR (69)
C-suite (1021)
Cystic fibrosis (96)
Data (6087)
Denatured (9)
Depression (118)
Dermatology (63)
Diabetes (385)
Diagnostics (4653)
Digital health (42)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (193)
Drug pricing (33)
Drug shortages (7)
Duchenne muscular dystrophy (225)
Earnings (78795)
Editorial (22)
Employer branding (3)
Employer resources (40)
Events (92345)
Executive appointments (928)
FDA (13295)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (25)
Funding (1119)
Gene editing (144)
Generative AI (17)
Gene therapy (412)
GLP-1 (419)
Government (1438)
Grass and pollen (2)
Guidances (313)
Healthcare (10776)
Hematology (108)
HIV (57)
Huntington's disease (28)
IgA nephropathy (69)
Immunology and inflammation (130)
Immuno-oncology (68)
Indications (165)
Infectious disease (1213)
Inflammatory bowel disease (150)
Inflation Reduction Act (6)
Influenza (91)
Intellectual property (281)
Interviews (84)
IPO (13589)
IRA (10)
Job creations (2183)
Job search strategy (506)
JPM (5)
Kidney cancer (17)
Labor market (16)
Layoffs (128)
Leadership (15)
Legal (5644)
Licensing (8)
Liver cancer (46)
Longevity (23)
Lung cancer (554)
Lymphoma (268)
Machine learning (33)
Management (10)
Manufacturing (633)
Marketing (10)
MASH (152)
Medical device (9510)
Medtech (9669)
Mergers & acquisitions (15861)
Metabolic disorders (850)
mRNA (71)
Multiple sclerosis (134)
NASH (6)
Neurodegenerative disease (264)
Neuropsychiatric disorders (53)
Neuroscience (2118)
NextGen: Class of 2026 (3607)
Non-profit (1187)
Now hiring (5)
Obesity (290)
Opinion (90)
Ovarian cancer (163)
Pain (185)
Pancreatic cancer (215)
Parkinson's disease (237)
Partnered (13)
Patents (532)
Patient recruitment (562)
Peanut (35)
People (47159)
Pharmaceutical (34)
Pharmacy benefit managers (14)
Phase 1 (16488)
Phase 2 (22808)
Phase 3 (15496)
Pipeline (8023)
Policy (75)
Postmarket research (1654)
Preclinical (6860)
Press Release (47)
Prostate cancer (211)
Psychedelics (25)
Radiopharmaceuticals (222)
Rare diseases (700)
Real estate (3325)
Recruiting (21)
Regulatory (16495)
Reports (29)
Research institute (793)
Resumes & cover letters (88)
Rett syndrome (42)
RNA editing (6)
RSV (50)
Schizophrenia (128)
Series A (210)
Series B (141)
Service/supplier (5)
Sickle cell disease (75)
Special edition (5)
Spinal muscular atrophy (100)
Sponsored (16)
Startups (2315)
State (1)
Stomach cancer (3)
Supply chain (63)
Tariffs (7)
The Weekly (16)
Vaccines (436)
Venture capital (43)
Weight loss (123)
Women's health (88)
Worklife (2)
Date
Today (54)
Last 7 days (255)
Last 30 days (1748)
Last 365 days (21226)
2026 (13828)
2025 (21308)
2024 (25305)
2023 (29045)
2022 (37736)
2021 (40366)
2020 (36666)
2019 (26406)
2018 (19935)
2017 (20918)
2016 (20072)
2015 (26191)
2014 (23136)
2013 (19358)
2012 (21453)
2011 (21753)
2010 (21430)
Location
Africa (327)
Alabama (76)
Alaska (4)
Arizona (316)
Arkansas (12)
Asia (22160)
Australia (2787)
California (12421)
Canada (3370)
China (756)
Colorado (553)
Connecticut (436)
Delaware (240)
Europe (36563)
Florida (1859)
Georgia (390)
Hawaii (3)
Idaho (46)
Illinois (757)
India (63)
Indiana (328)
Iowa (15)
Japan (462)
Kansas (107)
Kentucky (34)
Louisiana (29)
Maine (29)
Maryland (1311)
Massachusetts (8371)
Michigan (320)
Minnesota (588)
Mississippi (4)
Missouri (89)
Montana (22)
Nebraska (17)
Nevada (122)
New Hampshire (68)
New Jersey (2899)
New Mexico (17)
New York (3059)
North Carolina (1404)
North Dakota (4)
Northern California (6236)
Ohio (301)
Oklahoma (16)
Oregon (18)
Pennsylvania (2378)
Puerto Rico (23)
Rhode Island (35)
South America (545)
South Carolina (78)
South Dakota (1)
Southern California (5146)
Tennessee (129)
Texas (1987)
United States (41157)
Utah (370)
Vermont (1)
Virginia (170)
Washington D.C. (43)
Washington State (955)
West Virginia (1)
Wisconsin (81)
Wyoming (2)
525,670 Results for "alphatec holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results
August 7, 2026
·
11 min read
Press Releases
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
August 6, 2026
·
21 min read
Press Releases
Medpace Holdings, Inc. Reports Second Quarter 2026 Results
July 23, 2026
·
18 min read
FDA
REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans
The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five patients enrolled in REGENXBIO’s registrational trial. The biotech no longer plans to resubmit the candidate—which was rejected in February—in the near term.
August 24, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
August 13, 2026
·
1 min read
Press Releases
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
August 5, 2026
·
2 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
May 8, 2026
·
10 min read
Press Releases
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
July 9, 2026
·
1 min read
1 of 52,567
Next
